Aura Biosciences, Inc. (AURA) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Aura Biosciences, Inc. (AURA) Bundle
Designed for accuracy, our (AURA) DCF Calculator enables you to assess the valuation of Aura Biosciences, Inc. using real-world financial data, allowing complete flexibility to modify all essential parameters for improved projections.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -23.6 | -21.4 | -34.4 | -59.1 | -83.7 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | .5 | .8 | .8 | 1.2 | 1.3 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -24.1 | -22.2 | -35.3 | -60.3 | -85.0 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 32.4 | 17.4 | 149.1 | 188.8 | 226.2 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | 2.3 | .6 | 2.4 | 2.9 | 1.8 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -2.2 | -.8 | -2.1 | -1.1 | -.7 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | -0.17962 | -0.17962 | -0.17962 | -0.17962 | -0.17962 | -0.17962 | -0.17962 | -0.17962 | -0.17962 | -0.17962 |
| EBITAT | -24.1 | -22.2 | -34.4 | -58.7 | -85.1 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -23.5 | -23.9 | -33.9 | -58.1 | -85.7 | -1.8 | .0 | .0 | .0 | .0 |
| WACC, % | 5.93 | 5.93 | 5.92 | 5.92 | 5.93 | 5.93 | 5.93 | 5.93 | 5.93 | 5.93 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -2 | |||||||||
| Net Debt | -22 | |||||||||
| Equity Value | 20 | |||||||||
| Diluted Shares Outstanding, MM | 40 | |||||||||
| Equity Value Per Share | 0.50 |
What You Will Get
- Real AURA Financial Data: Pre-filled with Aura Biosciences’ historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Aura Biosciences’ intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive Data: Aura Biosciences' historical financial statements and pre-filled projections.
- Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
- Real-Time Insights: Observe Aura Biosciences' intrinsic value recalculating instantly.
- Intuitive Visualizations: Dashboard charts showcase valuation outcomes and essential metrics.
- Designed for Precision: A professional-grade tool tailored for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file for Aura Biosciences, Inc. (AURA).
- Step 2: Review the pre-filled financial data and forecasts for Aura Biosciences.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Analyze the outputs and leverage the results for your investment decisions.
Why Choose This Calculator for Aura Biosciences, Inc. (AURA)?
- Accurate Data: Utilize real Aura Biosciences financials for dependable valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Built-in calculations save you from starting from the ground up.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
- User-Friendly: Simple interface and guided instructions ensure accessibility for all users.
Who Should Use Aura Biosciences, Inc. (AURA)?
- Investors: Evaluate Aura's market potential before making investment decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and analyze financial forecasts.
- Startup Founders: Gain insights into how biotech companies like Aura are appraised.
- Consultants: Provide detailed valuation assessments for clients in the biotech sector.
- Students and Educators: Utilize current data to teach and practice valuation strategies in biotechnology.
What the Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations.
- Real-World Data: Aura Biosciences, Inc. (AURA)’s historical and projected financials preloaded for analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables to provide clear, actionable results.